Jinxin Fertility FY26 H1 swings to profit of RMB 110.3 million; revenue rises 6.6% to RMB 1.37 billion

• Jinxin Fertility posted IFRS net profit of RMB 110.3 million, returning to profit from a prior-year loss.
• IFRS profit attributable to owners was RMB 107.4 million, swinging from a prior-year loss; basic earnings per share were RMB 0.04.
• Revenue rose 6.6% to RMB 1.37 billion, with Greater China at RMB 985.8 million and overseas at RMB 387.5 million.
• Non-IFRS adjusted net profit climbed 79.8% to RMB 148 million; non-IFRS adjusted EBITDA increased 49.8% to RMB 336.5 million.
• California SB 729 entered implementation on Jan. 1, 2026, with IVF insurance coverage expected to phase in as large-group plans renew.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jinxin Fertility Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260821-12294277), on August 21, 2026, and is solely responsible for the information contained therein.